November 05, 2012 at 12:36 PM EST
BioMarin shares up 30% on treatment result
Shares of biotechnology company BioMarin climb more than 30% after positive results from treatment for rare disorder
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here